/
PFND
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $134.0K | $181.0K | $360.0K | $344.0K | $73.0K | $114.0K | $54.0K | $0 |
| Cost of revenue | $29.0K | $102.0K | $164.0K | $92.0K | $26.0K | $50.0K | $37.0K | $0 |
| Gross profit | $105.0K | $79.0K | $196.0K | $252.0K | $47.0K | $64.0K | $17.0K | $0 |
| Gross margin | 78.4% | 43.6% | 54.4% | 73.3% | 64.4% | 56.1% | 31.5% | — |
| R&D | $2.2M | $1.6M | $1.4M | $728.0K | $1.7M | $1.3M | $672.0K | $262.0K |
| Operating income | −$5.3M | −$4.6M | −$4.1M | −$2.5M | $3.9M | −$2.1M | −$1.6M | −$1.1M |
| EBITDA | −$5.2M | −$4.4M | −$4.1M | −$2.5M | −$3.6M | −$2.0M | −$1.6M | −$1.1M |
| Net income | −$4.6M | −$4.4M | −$4.1M | −$2.1M | −$18.9M | −$2.3M | −$1.8M | −$1.7M |
| Net margin | -3450.0% | -2433.1% | -1139.7% | -603.5% | -25920.5% | -1975.4% | -3353.7% | — |
| EPS (diluted) | -0.05 | -0.05 | -0.04 | -0.00 | -0.04 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
PATHFINDER CELL THERAPY
PATHFINDER CELL THERAPY
Held by traders on TradeandTell
No one on the platform currently holds PFND.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PFND as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PFND yet.